Central obesity and increased risk of dementia more than three decades later
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
To the Editor:
We read with interest the article by Whitmer et al.,1 who provide evidence of a longitudinal link between middle-life visceral obesity and dementia risk. It is now apparent that intra-abdominal fat may play a role in other health complications in addition to cardiovascular disease (CVD). Unfortunately, the underlying mechanisms are still unclear.
To explain the observations that overall adiposity is linked both to cognitive decline and CVD and that concurrent CVD is often seen in older patients with dementia, we recently reviewed current physiopathologic theories.2,3 We concluded that visceral adipose tissue (VAT) is consistently implicated in cognitive decline rather than body mass index.
In addition, women who experience changes in body composition and fat distribution after menopause transition are at an increased risk of Alzheimer disease (AD). This is due to a stronger link to vascular factors (proinflammatory molecules) and metabolic complications (insulin resistance, dyslipidemia, hypertension).3
Luchsinger et al. have hypothesized that in people over 65, a short-term (5-year follow-up) prospective association seems modified by age and is different depending on the anthropometric measure.4 However, a life course contribution to chronic diseases is recognized.2 The study by Whitmer et al.1 supports the previously suggested theory2,3 particularly when multiple adjustments for concurrent VAT-related complications (diabetes, hypertension, hyperlipidemia, and CVDs) are considered. In this respect, the role of VAT as endocrine organ, which is able to release a number of mediators, appears fundamental.
The confounding effect of insulin resistance should be recognized but it should also be noted that a chronic low-grade inflammation is a precondition associated with obesity duration. Reduction in VAT, particularly through physical activity, is efficacious in improving metabolic profile and inflammation. However, long-term …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Article
Adiposity is related to cerebrovascular and brain volumetry outcomes in the RUN DMC studyIlse A.C. Arnoldussen, Deborah R. Gustafson, Esther M.C. Leijsen et al.Neurology, July 30, 2019 -
Articles
Central obesity and increased risk of dementia more than three decades laterR. A. Whitmer, D. R. Gustafson, E. Barrett-Connor et al.Neurology, March 26, 2008 -
Brief Communications
Serum leptin changes in epileptic patients who gain weight after therapy with valproic acidA. Verrotti, F. Basciani, S. Morresi et al.Neurology, July 01, 1999 -
Brief Communications
Leptin, ghrelin, and adiponectin in epileptic patients treated with valproic acidR. Greco, G. Latini, F. Chiarelli et al.Neurology, December 12, 2005